Back
Editas Medicine Vs. Equinix Industry Stock Comparison
Sell
49
EDIT
Editas Medicine
Last Price:
$3.04
Seasonality Move:
-16.44%
Buy
53
EQIX
Equinix
Last Price:
$781.38
Seasonality Move:
0.02%
Sell
49
Editas Medicine (EDIT)
is a Sell
Is Editas Medicine a Buy, Sell or Hold?
-
The current Editas Medicine [EDIT] share price is $3.03. The Score for EDIT is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
-
EDIT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
EDIT Stock Price Chart
What is Editas Medicine's stock price today?
-
The Editas Medicine share price today is $3.03Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EDIT is experiencing slight buying pressure.
EQIX Stock Price Chart
EDIT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.69 | Buy |
Relative Strength Index (14 RSI): | 59.27 | Buy |
Chaikin Money Flow: | 1476002 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.43 - 3.11) | Buy |
Bollinger Bands (100): | (1.34 - 2.64) | Buy |
EQIX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 189.97 | Buy |
Relative Strength Index (14 RSI): | 46.48 | Sell |
Chaikin Money Flow: | 114065 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (770.16 - 795.08) | Sell |
Bollinger Bands (100): | (774.8 - 874.84) | Sell |
EDIT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.6 | Buy |
20-day SMA: | 2.77 | Buy |
50-day SMA: | 2.54 | Buy |
200-day SMA: | 1.92 | Buy |
8-day EMA: | 2.64 | Buy |
20-day EMA: | 1.98 | Buy |
50-day EMA: | 1.11 | Buy |
200-day EMA: | 0.34 | Buy |
EQIX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 779.16 | Buy |
20-day SMA: | 786.31 | Sell |
50-day SMA: | 811.62 | Sell |
200-day SMA: | 872.55 | Sell |
8-day EMA: | 757.17 | Buy |
20-day EMA: | 588.7 | Buy |
50-day EMA: | 335.29 | Buy |
200-day EMA: | 102.21 | Buy |
Editas Medicine Earnings Growth & EDIT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.40 per share, an increase next quarter of $0.03 per share, an increase this year of $0.65 per share, and an increase next year of $0.94 per share.
Equinix Earnings Growth & EQIX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.64 per share, an increase next quarter of $0.25 per share, an increase this year of $3.85 per share, and an increase next year of $0.32 per share.
Editas Medicine Technical Analysis
Aug 4 | Aug 5 | Aug 6 | Aug 7 | Aug 8 | Aug 11 | Aug 12 | Aug 13 | Aug 14 | Aug 15 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | ||||||||||
04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Equinix Technical Analysis
Aug 4 | Aug 5 | Aug 6 | Aug 7 | Aug 8 | Aug 11 | Aug 12 | Aug 13 | Aug 14 | Aug 15 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | ||||||||||
04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |